Obesity is a known risk factor for pancreatic cancer, a disease with a five-year survival of only 9 percent, but little is known about how, or if, the disease behaves differently in obese vs. lean individuals. In a study published today in the journal Nature Communications, a researcher funded by the Pancreatic Cancer Action Network (PanCAN), focuses on understanding genetic changes in pancreatic tumors grown in obese mice vs. lean mice.
The study validates the direct link to obesity and exposes potential treatment options for patients within this group. Read more . . .